MicroRNAs as newer therapeutic targets: A big hope from a tiny player

Journal of Pharmacology and Pharmacotherapeutics

Volumn 3, Issue 3, 2012, Pages 217-227

  Ghelani, Hardik S ^a   Rachchh, Manish A ^a   Gokani, Rina H ^a  

^a S J Thakkar Pharmacy College   (India)

Author keywords

Antagomere; cancer; cardiovascular; diabetes; microRNAs; target genes

Indexed keywords

MICRORNA; MICRORNA 1; MICRORNA 21; MICRORNA 29; MICRORNA 34A; MICRORNA 375;

BIOGENESIS; DEGENERATIVE DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG TARGETING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GLUCOSE HOMEOSTASIS; HEART FAILURE; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; LIPID METABOLISM; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; TRANSCRIPTION REGULATION; VALVULAR HEART DISEASE;

EID: 84865060978     PISSN: 0976500X     EISSN: None     Source Type: Journal    
DOI: 10.4103/0976-500X.99416     Document Type: Review

References (106)

1. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993;75:843-54. (Pubitemid 24014542)
2. Gary Ruvkun. Glimpses of a Tiny RNA World. Science 2001;294:797-9.
3. Bartel DP. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004;116:281-97.
4. Lee Y, Kim M, Han J. MicroRNA genes are transcribed by RNA polymerase II. Embo J 2004;23:4051-60. (Pubitemid 39472426)
5. Lee Y, Ahn C, Han J. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003;425:415-6.
6. Wang Y, Medvid R, Melton C, Jaenisch R, Blelloch R. DGCR8 is essential for microRNA biogenesis and silencing of embryonic stem cell self-renewal. Nat Genet 2007;39:380-5. (Pubitemid 46328490)
7. Bohnsack MT, Czaplinski K, Gorlich D. Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs. RNA 2004;10:185-91. (Pubitemid 38129823)
8. Hutvagner G, McLachlan J, Pasquinelli AE, Balint E, Tuschl T, Zamore PD. A cellular function for the RNA interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 2001;293:834-8. (Pubitemid 32743968)
9. Schwarz DS, Hutvagner G, Du T, Xu Z, Aronin N, Zamore PD. Asymmetry in the assembly of the RNAi enzyme complex. Cell 2003;115:199-208. (Pubitemid 37329583)
10. Khvorova A, Reynolds A, Jayasena SD. Functional siRNAs and miRNAs exhibit strand bias. Cell 2003;115:209-16. (Pubitemid 37329584)
11. Liu J, Carmell MA, Rivas FV. Argonaute2 is the catalytic engine of mammalian RNAi. Science 2004;305:1437-41. (Pubitemid 39167657)
12. Liu J, Valencia-Sanchez MA, Hannon GJ, Parker R. MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies. Nat Cell Biol 2005;7:719-23. (Pubitemid 40975754)
13. Naraba H, Iwai N. Assessment of the microRNA system in salt-sensitive hypertension. Hypertens Res 2005;28:819-26. (Pubitemid 47400252)
14. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T. Identification of tissue-specific microRNAs from mouse. Curr Biol 2002;12:735-9. (Pubitemid 34455427)
15. Ji R, Cheng Y, Yue J. MicroRNA expression signature and antisensemediated depletion reveal an essential role of microRNA in vascular neointimal lesion formation. Circ Res 2007;100:1579-88. (Pubitemid 46897261)
16. Cheng Y, Ji R, Yue J. MicroRNAs are aberrantly expressed in hypertrophic heart: Do they play role in cardiac hypertrophy? Am J Pathol 2007;170: 1831-40. (Pubitemid 47339258)
17. van Rooij E, Sutherland L, Liu N. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci 2007;103:18255-60. (Pubitemid 44871645)
18. Sayed D, Hong C, Chen I, Lypowy J, Abdellatif M. MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ Res 2007;100:416-24.
19. Zhao Y, Samal E, Srivastava D. Serum response factor regulates a musclespecific microRNA that targets Hand2 during cardiogenesis. Nature 2005;436:214-20. (Pubitemid 41021266)
20. Van Rooij E, Sutherland L, Qi X, Richardson J, Hill J, Olson E. Control of stress dependent cardiac growth and gene expression by a microRNA. Science 2007;316:575-9. (Pubitemid 46683138)
21. Tatsuguchi M, Seok H, Callis T. Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. J Mol Cell Cardiol 2007;42:1137-41. (Pubitemid 46829201)
22. Carè A, Catalucci D, Felicetti F. MicroRNA-133 controls cardiac hypertrophy. Nat Med 2007;13:613-8. (Pubitemid 46828487)
23. Thum T, Galuppo P, Wolf C. MicroRNAs in the human heart: A clue to fetal gene reprogramming in heart failure. Circulation 2007;116:258-67. (Pubitemid 47196561)
24. Elmen J, Lindow M, Schutz S. LNA-mediated microRNA silencing in non-human primates. Nature 2008;452:896-9. (Pubitemid 351550859)
25. Sokol N, Ambros V. Mesodermally expressed Drosophila microRNA-1 is regulated by Twist and is required in muscles during larval growth. Genes Dev 2005;19:2343-54. (Pubitemid 41396911)
26. Kwon C, Han Z, Olson E, Srivastava, D. MicroRNA1 influences cardiac differentiation in Drosophila and regulates Notch signaling. Proc Natl Acad Sci 2005;102:18986-91. (Pubitemid 43049553)
27. Zhao Y, Ransom J, Li A. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 2007;129:303-17. (Pubitemid 46574975)
28. Yang W, Yang D, Na S, Sandusky G, Zhang Q, Zhao G. Dicer is required for embryonic angiogenesis during mouse development. J Biol Chem 2005;280:9330-5. (Pubitemid 40409626)
29. Chen JF, Murchison EP, Tang R, Callis TE, Tatsuguchi M, Deng Z, et al. Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure. Proc Natl Acad Sci USA 2008;105:2111-6. (Pubitemid 351439473)
30. Ikeda S, Kong SW, Lu J, Bisping E, Zhang H, Allen PD, et al. Altered microRNA expression in human heart disease. Physiol Genomics 2007;31:367-73. (Pubitemid 350127777)
31. Tatsuguchi M, Seok HY, Callis TE, Thomson JM, Chen JF, Newman M, et al. Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. J Mol Cell Cardiol 2007;42:1137-41. (Pubitemid 46829201)
32. Thum T, Galuppo P, Wolf C, Fiedler J, Kneitz S, Van Laake LW, et al. MicroRNAs in the human heart: A clue to fetal gene reprogramming in heart failure. Circulation 2007;116:258-67. (Pubitemid 47196561)
33. Thum T, Gross C, Fiedler J. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 2008;21:253-60.
34. Peter TN, Wang-Xia W, Bernard W, Rajeev M. MicroRNAs (miRNAs) in Neurodegenerative Diseases. Brain Pathol 2008;18:130-8
35. Coppede F, Mancuso M, Siciliano G, Migliore L, Murri L. Genes and the environment in neurodegeneration. Biosci Rep 2006;26:341-67. (Pubitemid 44730317)
36. Price DL, Sisodia SS, Borchelt DR. Genetic neurodegenerative diseases: The human illness and transgenic models. Science 1998;282:1079-83. (Pubitemid 28516230)
37. Pearson H. Genetics: What is a gene? Nature 2006;441:398-401.
38. Huttenhofer A, Schattner P, Polacek N. Non-coding RNAs: Hope or hype Trends Genet 2005;21:289-97.
39. Arendt T. Alzheimer's disease as a disorder of dynamic brain selforganization. Prog Brain Res 2005;147:355-78.
40. Goedert M. Tau protein and neurodegeneration. Semin Cell Dev Biol 2004;15:45-9. (Pubitemid 38177367)
41. Markesbery WR, Lovell MA. Damage to lipids, proteins, DNA, and RNA in mild cognitive impairment. Arch Neurol 2007;64:954-6. (Pubitemid 47047994)
42. Nelson PT, Keller JN. RNA in brain disease: No longer just "the messenger in the middle". J Neuropathol Exp Neurol 2007;66:461-8. (Pubitemid 46869688)
43. Williams MM, Xiong C, Morris JC, Galvin JE. Survival and mortality differences between dementia with Lewy bodies vs Alzheimer disease. Neurology 2006;67:1935-41. (Pubitemid 44967367)
44. Reiman EM, Chen K, Alexander GE, Caselli RJ, Bandy D, Osborne D. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc Natl Acad Sci USA 2004;101:284-9. (Pubitemid 38084242)
45. Hardy J. Alzheimer's disease: The amyloid cascadehypothesis: An update and reappraisal. J Alzheimers Dis 2006;9:151-3. (Pubitemid 44253307)
46. Hebert SS, De Strooper B. MiRNAs in neurodegeneration. Science 2007;317:1179-80.
47. St George-Hyslop P, Haass C. Regulatory RNA goes awry in Alzheimer's disease. Nat Med 2008;14:711-2 (Pubitemid 351951508)
48. Nelson PT, Keller JN. RNA in brain disease: No longer just 'the messenger in the middle'. J Neuropathol Exp Neurol 2007;66:461-8. (Pubitemid 46869688)
49. Faghihi MA. Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of bsecretase. Nat Med 2008;14:723-30.
50. Mus E. Dendritic BC200 RNA in aging and in Alzheimer's disease. Proc Natl Acad Sci U. S. A 2007;104:10679-84. (Pubitemid 47185724)
51. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-53. (Pubitemid 38579764)
52. Gauthier BR, Wollheim CB. MicroRNAs: 'Ribo-regulators' of glucose homeostasis. Nat Med 2006;12:36-8. (Pubitemid 43050057)
53. Poy MN, Eliasson L, Krutzfeldt J, Kuwajima S, Ma X, Macdonald PE, et al. Pancreatic isletspecific microRNA regulates insulin secretion. Nature 2004;432:226-30. (Pubitemid 39545853)
54. Tang X, Tang G, Ozcan S. Role of microRNAs in diabetes. Biochim Biophys Acta 2008;1779:697-701.
55. Cuellar TL, McManus MT. MicroRNA and endocrine biology. J Endocrinol 2005;187:327-32.
56. Ouaamari AE, Baroukh N, Martens GA, Lebrun P, Pipeleers D, Van OE. MiR-375 targets 3'-phosphoinositide-dependent protein kinase-1 and regulates glucoseinduced biological responses in pancreatic beta-cells. Diabetes 2008;57:2708-17.
57. Plaisance V, Abderrahmani A, Perret-Menoud V, Jacquemin P, Lemaigre F, Regazzi R. MicroRNA-9 controls the expression of Granuphilin/Slp4 and the secretory response of insulin-producing cells. J Biol Chem 2006;281:26932-42. (Pubitemid 44401722)
58. Coppola T, Frantz C, Perret-Menoud V, Gattesco S, Hirling H, Regazzi R. Pancreatic beta-cell protein granuphilin binds Rab3 and Munc-18 and controls exocytosis. Mol Biol Cell 2002;13:1906-15. (Pubitemid 34651481)
59. Gomi H, Mizutani S, Kasai K, Itohara S, Izumi T. Granuphilin molecularly docks insulin granules to the fusion machinery. J Cell Biol 2005;171:99-109. (Pubitemid 41434605)
60. Baroukh N, Ravier MA, Loder MK, Hill EV, BounacerA, Scharfmann R, et al. MicroRNA-124a regulates Foxa2 expression and intracellular signaling in pancreatic betacell lines. J Biol Chem 2007;282:19575-88. (Pubitemid 47100119)
61. Vousden KH, Lane DP. P53 in health and disease. Nat Rev Mol Cell Biol 2007;8:275-83. (Pubitemid 46474662)
62. Bommer GT, Gerin I, Feng Y, Kaczorowski AJ, Kuick R, Love RE, et al. P53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr Biol 2007;17:1298-307. (Pubitemid 47176893)
63. Wrede CE, Dickson LM, Lingohr MK, Briaud I, Rhodes CJ. Protein kinase B/Akt prevents fatty acid-induced apoptosis in pancreatic beta-cells INS-1. J Biol Chem 2002;277:49676-84. (Pubitemid 36014411)
64. Kim WH, Lee JW, Gao B, Jung MH. Synergistic activation of JNK/SAPK induced by TNF-alpha and IFN-gamma: Apoptosis of pancreatic beta-cells via the p53 and ROS pathway. Cell Signal 2005;17:1516-32. (Pubitemid 41253991)
65. Taganov KD, Boldin MP, Chang KJ, Baltimore D. NF-kappaB-dependent induction of microRNA miR-146 an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 2006;103:12481-6. (Pubitemid 44267285)
66. Dunne A, O'Neill LA. The interleukin-1 receptor/Toll-like receptor superfamily: Signal transduction during inflammation and host defense. Sci STKE 2003;171: re3.
67. He A, Zhu L, Gupta N, Chang Y, Fang F. Overexpression of micro ribonucleic acid 29 highly up-regulated in diabetic rats leads to insulin resistance in 3T3-L1 adipocytes. Mol Endocrinol 2007;21:2785-94. (Pubitemid 350035159)
68. Baroni MG, Arca M, Sentinelli F, Buzzetti R, Capici F, Lovari S, et al. The G972R variant of the insulin receptor substrate-1 IRS-1 gene body fat distribution and insulin-resistance. Diabetologia 2001;44:367-72. (Pubitemid 32234465)
69. Shi B, Sepp-Lorenzino L, Prisco M, Linsley P, deAngelis T, Baserga R. Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells. J Biol Chem 2007;282:32582-90. (Pubitemid 350159311)
70. Lewis GF, Carpentier A, Adeli K, Giacca A. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev 2002;23:201-29. (Pubitemid 34299024)
71. Xu P, Vernooy SY, Guo M, Hay BA. The Drosophila microRNA Mir-14 suppresses cell death and is required for normal fat metabolism. Curr Biol 2003;13:790-5. (Pubitemid 36531030)
72. Teleman AA, Maitra S, Cohen SM. Drosophila lacking microRNA miR-278 are defective in energy homeostasis. Genes Dev 2006;20:417-22. (Pubitemid 43244395)
73. Esau C, Davis S, Murray SF. MiR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 2006;3:87-98.
74. Krutzfeldt J, Rajewsky N, Braich K. Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005;438:685-9.
75. Esau C, Kang X, Peralta E. MicroRNA-143 regulates adipocyte differentiation. J Biol Chem 2004;279:52361-5. (Pubitemid 39656612)
76. Xiao J, Luo X, Lin H. MicroRNA miR-133 represses HERG K+ channel expression contributing to QT prolongation in diabetic hearts. J Biol Chem 2007;282:12363-7. (Pubitemid 47100573)
77. Collins KK, Van Hare GF. Advances in congenital long QT syndrome. Curr Opin Pediatr 2006;18:497-02. (Pubitemid 44401285)
78. Chen HS, Shan YX, Yang TL, Lin HD, Chen JW, Lin SJ. Insulin deficiency downregulated heat shock protein 60 and IGF-1 receptor signaling in diabetic myocardium. Diabetes 2005;54:175-81.
79. Shan YX, Yang TL, Mestril R, Wang PH. Hsp10 and Hsp60 suppress ubiquitination of insulin-like growth factor-1 receptor and augment insulinlike growth factor-1 receptor signaling in cardiac muscle: Implications on decreased myocardial protection in diabetic cardiomyopathy. J Biol Chem 2003;278:45492-8. (Pubitemid 37432688)
80. Wang XH, Qian RZ, Zhang W, Chen SF, Jin HM, Hu RM. MicroRNAs-320 expression in myocardial microvascular endothelial cells and its relationship with insulin-like growth factor-1 in type 2 diabetic rats. Clin Exp Pharmacol Physiol 2009;36:181-8.
81. Price RG, Hudson BG. In Renal Basement Membranes in Health and Disease. Boston: Academic Press; 1987. p. 1-439.
82. Yin HB, Brown T, Wilkinson JS, Eason RW, Melvin T. Submicron patterning of DNA oligonucleotides on silicon. Nucleic Acids Res 2004;32:118-21.
83. Kato M, Zhang J, Wang M, Lanting L, Yuan H, Rossi JJ, et al. MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proc Natl Acad Sci USA 2007;104:3432-7. (Pubitemid 46364176)
84. Wang Q, Wang Y, Minto AW, Wang J, Shi Q, Li X. MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy. FASEB J 2008;22:4126-35.
85. Calin GA, Dumitru CD, Shimizu M. Frequent deletions and downregulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002;99:15524-9. (Pubitemid 35403967)
86. Lu J, Getz G, Miska EA. MicroRNA expression profiles classify human cancers. Nature 2005;435:834-8. (Pubitemid 40839735)
87. Shimono Y, Zabala M, Cho RW. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 2009;138:592-603.
88. Zhang B, Pan X, Cobb GP, Anderson TA. MicroRNAs as oncogenes and tumor suppressors. Dev Biol 2007;302:1-12. (Pubitemid 46096921)
89. Hayashita Y, Osada H, Tatematsu Y. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 2005;65:9628-32. (Pubitemid 41541436)
90. Dews M, Homayouni A, Yu D. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat Genet 2006;38:1060-5. (Pubitemid 44325933)
91. Chan JA, Krichevsky AM, Kosik KS. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 2005;65:6029-33. (Pubitemid 40994386)
92. Si ML, Zhu S, Wu H. MiR-21-mediated tumor growth. Oncogene 2007;26:2799-803. (Pubitemid 46663837)
93. Asangani IA, Rasheed SA, Nikolova DA. MicroRNA-21 (miR-21) posttranscriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 2008;27:2128-36. (Pubitemid 351485639)
94. Li Y, Li W, Yang Y. MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiforme. Brain Res 2009;1286:13-8.
95. Qin W, Zhao B, Shi Y. BMPRII is a direct target of miR-21. Acta Biochim Biophys Sin 2009;41:618-23.
96. Greither T, Grochola LF, Udelnow A. Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival. Int J Cancer 2010;126:73-80.
97. Gironella M, Seux M, Xie MJ. Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. Proc Natl Acad Sci USA 2007;104:16170-5. (Pubitemid 350099380)
98. Voorhoeve PM, le SC, Schrier M. A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell 2006;124:1169-81.
99. Takamizawa J, Konishi H, Yanagisawa K. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 2004;64:3753-6. (Pubitemid 38697282)
100. Calin GA, Cimmino A, Fabbri M. MiR-15a and miR-16-1 cluster functions in human leukemia. Proc Natl Acad Sci USA 2008;105:5166-71. (Pubitemid 351738528)
101. Cimmino A, Calin GA, Fabbri M. MiR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 2005;102:13944-9. (Pubitemid 41377683)
102. Takeshita F, Patrawala L, Osaki M. Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via down regulation of multiple cell-cycle genes. Mol Ther 2010;18:181-7.
103. Bonci D, Coppola V, Musumeci M. The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat Med 2008;14:1271-7.
104. Johnson SM, Grosshans H, Shingara J. RAS is regulated by the let-7 microRNA family. Cell 2005;120:635-47. (Pubitemid 40343076)
105. Chang TC, Wentzel EA, Kent OA. Trans activation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 2007;26:745-52.
106. Ji Q, Hao X, Zhang M, Tang W, Yang M, Li L, Xiang D, et al. MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. PLoS One 2009;4: e6816.